{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:27:38Z","timestamp":1793212058913,"version":"4.5.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n            <jats:title>Background and aim<\/jats:title>\n            <jats:p>Diagnostic and management guidelines for vitamin B<jats:sub>12<\/jats:sub> (cobalamin, Cbl) deficiency in inflammatory bowel disease (IBD) are lacking. True deficiency is defined as Cbl concentrations below reference range combined with elevated methylmalonic acid (MMA) concentrations. Studies analyzing Cbl status in IBD use only Cbl concentrations without confirmatory MMA. This study aims to determine the proportion of IBD patients with Cbl concentrations below reference range and their predisposing clinical and genetic characteristics. We then compared this to the proportion with true deficiency.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and methods<\/jats:title>\n            <jats:p>In a prospective observational pilot study of adult IBD outpatients, Cbl concentrations, MMA levels, and fucosyltransferase 2 mutations were measured at clinic visits.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 66 Crohn\u2019s disease (CD) and 30 ulcerative colitis (UC) patients were recruited. Mean Cbl concentrations (pmol\/l) in CD (253.7) were not significantly lower than UC (320.5, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.24). Serum Cbl below reference range (&lt;148) was observed in 7.6 and 10% of CD and UC patients, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.70). True deficiency in CD and UC was 3 and 3.3%, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic>=1.0). Patients with ileal resections more than 30\u2009cm had lower mean Cbl concentrations (177, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.02) and a trend toward higher proportions with Cbl levels below reference range (40%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.06), but not increased deficiency rates (0%, <jats:italic toggle=\"yes\">P<\/jats:italic>=1.0). Disease location, severity, and fucosyltransferase 2 mutations were not associated with altered Cbl status.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>True Cbl deficiency was rare in IBD patients in this study. A disparity in Cbl status exists when confirmatory MMA levels are used compared with Cbl concentrations alone. Asymptomatic IBD patients with low serum Cbl require confirmatory tests to guide management and avoid unnecessary treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/meg.0000000000000970","type":"journal-article","created":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T17:20:57Z","timestamp":1506446457000},"page":"1361-1367","source":"Crossref","is-referenced-by-count":15,"title":["Vitamin B12 deficiency in inflammatory bowel disease: a prospective observational pilot study"],"prefix":"10.1097","volume":"29","author":[{"given":"Robert","family":"Battat","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University Health Centre"},{"name":"Division of Gastroenterology, Department of Medicine, Jewish General Hospital, Montreal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Kopylov","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sheba Medical Center Tel Hashomer and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Byer","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maida J.","family":"Sewitch","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology, Department of Medicine, Research Institute of the McGill University Health Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Rahme","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology, Department of Medicine, Research Institute of the McGill University Health Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hacene","family":"Nedjar","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology, Department of Medicine, Research Institute of the McGill University Health Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elana","family":"Zelikovic","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Dionne","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University Health Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talat","family":"Bessissow","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University Health Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqqas","family":"Afif","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University Health Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula J.","family":"Waters","sequence":"additional","affiliation":[{"name":"Medical Genetics Service, Department of Medicine, Centre Hospitalier Universitaire de Sherbrooke (CHUS), University of Sherbrooke, Sherbrooke"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Seidman","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University Health Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bitton","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University Health Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/archinte.159.12.1289","article-title":"Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician","volume":"159","author":"Snow","year":"1999","journal-title":"Arch Intern Med"},{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ibd.21785","article-title":"Homocysteinemia and B vitamin status among adult patients with inflammatory bowel disease: a one-year prospective follow-up study","volume":"18","author":"Vagianos","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"R3-20230916","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ibd.20282","article-title":"Prevalence of and risk factors for vitamin B(12) deficiency in patients with Crohn\u2019s disease","volume":"14","author":"Headstrom","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"Pt 2","key":"R4-20230916","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/0016-5085(79)90389-5","article-title":"Clinical features and natural history of Crohn\u2019s disease","volume":"77","author":"Mekhjian","year":"1979","journal-title":"Gastroenterology"},{"key":"R6-20230916","first-page":"1120","article-title":"Vitamin B12 deficiency in inflammatory bowel disease: prevalence, risk factors, evaluation, and management","volume":"20","author":"Battat","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"R7-20230916","doi-asserted-by":"crossref","first-page":"348s","DOI":"10.3945\/ajcn.111.013441","article-title":"Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II","volume":"94","author":"Carmel","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"R8-20230916","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3945\/ajcn.2009.28835","article-title":"Does high folic acid intake affect unrecognized cobalamin deficiency, and how will we know it if we see it?","volume":"90","author":"Carmel","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"R9-20230916","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/MOG.0b013e3283505852","article-title":"Subclinical cobalamin deficiency","volume":"28","author":"Carmel","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"key":"R10-20230916","doi-asserted-by":"crossref","first-page":"313s","DOI":"10.3945\/ajcn.111.013243","article-title":"Biomarkers of vitamin B-12 status in NHANES: a roundtable summary","volume":"94","author":"Yetley","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1017\/S1368980009990279","article-title":"Association between vitamin B12-containing supplement consumption and prevalence of biochemically defined B12 deficiency in adults in NHANES III (third national health and nutrition examination survey)","volume":"13","author":"Evatt","year":"2010","journal-title":"Public Health Nutr"},{"key":"R12-20230916","doi-asserted-by":"crossref","first-page":"666s","DOI":"10.3945\/ajcn.110.009613","article-title":"Indicators for assessing folate and vitamin B-12 status and for monitoring the efficacy of intervention strategies","volume":"94","author":"Green","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"R13-20230916","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0002-9343(94)90149-X","article-title":"Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies","volume":"96","author":"Savage","year":"1994","journal-title":"Am J Med"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1056\/NEJMcp1113996","article-title":"Clinical practice. Vitamin B12 deficiency","volume":"368","author":"Stabler","year":"2013","journal-title":"N Engl J Med"},{"key":"R15-20230916","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2796.1990.tb00248.x","article-title":"The relationship between clinically confirmed cobalamin deficiency and serum methylmalonic acid","volume":"228","author":"Moelby","year":"1990","journal-title":"J Intern Med"},{"key":"R16-20230916","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.nut.2006.08.017","article-title":"Vitamin B12 malabsorption in patients with limited ileal resection","volume":"22","author":"Duerksen","year":"2006","journal-title":"Nutrition"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/gut.45.3.389","article-title":"Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications","volume":"45","author":"Mahmud","year":"1999","journal-title":"Gut"},{"key":"R18-20230916","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/ibd.20285","article-title":"Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases","volume":"13","author":"Gasche","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R19-20230916","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejim.2010.05.007","article-title":"Serum vitamin B12 and folate status in patients with inflammatory bowel diseases","volume":"21","author":"Yakut","year":"2010","journal-title":"Eur J Intern Med"},{"key":"R20-20230916","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/j.1572-0241.2007.01170.x","article-title":"Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine","volume":"102","author":"Peyrin-Biroulet","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R21-20230916","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00042737-200603000-00005","article-title":"Clinical outcome of Crohn's disease according to the Vienna classification: disease location is a useful predictor of disease course","volume":"18","author":"Oostenbrug","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R22-20230916","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/14017430601049449","article-title":"Comparing costs of intramuscular and oral vitamin B12 administration in primary care: a cost-minimization analysis","volume":"12","author":"Vidal-Alaball","year":"2006","journal-title":"Eur J Gen Pract"},{"key":"R23-20230916","first-page":"79","article-title":"Vitamin B12 injections versus oral supplements. How much money could be saved by switching from injections to pills?","volume":"47","author":"Van Walraven","year":"2001","journal-title":"Can Fam Physician"},{"key":"R24-20230916","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1093\/hmg\/ddq248","article-title":"Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn\u2019s disease","volume":"19","author":"McGovern","year":"2010","journal-title":"Hum Mol Genet"},{"key":"R25-20230916","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn\u2019s-disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"R26-20230916","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/ibd.20520","article-title":"Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis","volume":"14","author":"Lewis","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R27-20230916","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ng.210","article-title":"Common variants of FUT2 are associated with plasma vitamin B12 levels","volume":"40","author":"Hazra","year":"2008","journal-title":"Nat Genet"},{"key":"R28-20230916","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/ismej.2014.64","article-title":"Reprograming of gut microbiome energy metabolism by the FUT2 Crohn\u2019s disease risk polymorphism","volume":"8","author":"Tong","year":"2014","journal-title":"ISME J"},{"key":"R29-20230916","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ng.717","article-title":"Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci","volume":"42","author":"Franke","year":"2010","journal-title":"Nat Genet"},{"key":"R30-20230916","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.0954-6820.1968.tb02452.x","article-title":"Oral treatment of pernicious anemia with high doses of vitamin B12 without intrinsic factor","volume":"184","author":"Berlin","year":"1968","journal-title":"Acta Med Scand"},{"key":"R31-20230916","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/S0149-2918(03)90096-8","article-title":"Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study","volume":"25","author":"Bolaman","year":"2003","journal-title":"Clin Ther"},{"key":"R32-20230916","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.clinthera.2011.03.003","article-title":"Comparing the efficacy and tolerability of a new daily oral vitamin B12 formulation and intermittent intramuscular vitamin B12 in normalizing low cobalamin levels: a randomized, open-label, parallel-group study","volume":"33","author":"Castelli","year":"2011","journal-title":"Clin Ther"},{"key":"R33-20230916","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1182\/blood.V92.4.1191","article-title":"Effective treatment of cobalamin deficiency with oral cobalamin","volume":"92","author":"Kuzminski","year":"1998","journal-title":"Blood"},{"key":"R34-20230916","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1007\/BF01303168","article-title":"Multiple vitamin status in Crohn\u2019s disease. Correlation with disease activity","volume":"38","author":"Kuroki","year":"1993","journal-title":"Dig Dis Sci"},{"key":"R35-20230916","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00384-003-0556-2","article-title":"Should we monitor vitamin B12 levels in patients who have had end-ileostomy for inflammatory bowel disease?","volume":"19","author":"Jayaprakash","year":"2004","journal-title":"Int J Colorectal Dis"},{"key":"R36-20230916","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2141.1982.tb03914.x","article-title":"Haematological aspects of life with an ileostomy","volume":"52","author":"Kennedy","year":"1982","journal-title":"Br J Haematol"},{"key":"R37-20230916","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.crohns.2010.10.010","article-title":"Prevalence and risk factors of hyperhomocysteinemia in Tunisian patients with Crohn\u2019s disease","volume":"5","author":"Kallel","year":"2011","journal-title":"J Crohns Colitis"},{"key":"R38-20230916","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MCG.0b013e318046eab0","article-title":"Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications","volume":"42","author":"Erzin","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"R39-20230916","doi-asserted-by":"crossref","first-page":"712s","DOI":"10.3945\/ajcn.2008.26947E","article-title":"Is it time for vitamin B-12 fortification? What are the questions?","volume":"89","author":"Green","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"R40-20230916","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1097\/MIB.0000000000000559","article-title":"Prevalence and risk factors for functional vitamin B12 deficiency in patients with Crohn\u2019s disease","volume":"21","author":"Ward","year":"2015","journal-title":"Inflamm Bowel Dis"}],"container-title":["European Journal of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00042737-201712000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T15:03:26Z","timestamp":1694876606000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042737-201712000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000000970","relation":{},"ISSN":["0954-691X"],"issn-type":[{"value":"0954-691X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}